Cellectis S.A. (EPA:ALCLS)
France · Delayed Price · Currency is EUR 2.985
+0.020 (0.67%)
Sep 26, 2025, 5:35 PM CET
Cellectis Market Cap
Cellectis has a market cap or net worth of €215.89 million as of September 26, 2025. Its market cap has increased by 45.29% in one year.
Market Cap
215.89M
Enterprise Value
242.42M
Revenue
54.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.99
Market Cap Chart
Since February 7, 2007, Cellectis's market cap has increased from 100.59M to 215.89M, an increase of 114.61%. That is a compound annual growth rate of 4.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 215.89M | 84.07% |
| Dec 31, 2024 | 117.29M | -40.86% |
| Dec 29, 2023 | 198.32M | 118.98% |
| Dec 30, 2022 | 90.57M | -73.23% |
| Dec 31, 2021 | 338.35M | -67.37% |
| Dec 31, 2020 | 1.04B | 55.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 125.29B |
| Sanofi | 95.30B |
| Sartorius Stedim Biotech | 16.69B |
| bioMérieux | 13.34B |
| Eurofins Scientific SE | 10.82B |
| Ipsen | 9.19B |
| ABIVAX Société Anonyme | 5.31B |
| Virbac | 2.63B |